The future of CART in the era of drug eluting stents: "It's not over until it's over"

Brachytherapy

Volumn 2, Issue 2, 2003, Pages 74-76

  Tripuraneni, Prabhakar ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FLUOROURACIL; METHOTREXATE; PACLITAXEL; RAPAMYCIN;

ARTERY INTIMA PROLIFERATION; BRACHYTHERAPY; CLINICAL TRIAL; CORONARY ARTERY; CORONARY STENT; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RESTENOSIS; SHORT SURVEY; TREATMENT OUTCOME;

EID: 0041560049     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-4721(03)00104-1     Document Type: Article

References (9)

1. Teirstein P.S., Massullo V., Jani S.K., et al. Catheter based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 336:1997;1697-1703.
2. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 334:2001;250-256.
3. Waksman R., Raizner A.E., Yeung A.C., et al. Use of localized intracoronary beta radiation in the treatment of in-stent restenosis: the INHIBIT randomized controlled trial. Lancet. 359:2002;543-544.
4. Popma J.J., Suntharalingam M., Lansky A.J., et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 106:2002;1090-1096.
5. Waksman R., Cheneau E., Ajani A.E., et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation. 107:2003;1744-1749.
6. Waksman R., Ajani A.E., White R.I., et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med. 346:2002;1194-1199.
7. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780.
8. Final results of of large scale US study confirm Positive performance of Cordis CYPHER Sirolimus-Eluting stent, Johnson & Johnson press release, September 24, 2002.
9. Teirstein P.S., King S. Vascular radiation in a drug eluting stent world. It's not over till it's over. Circulation. 2003;. In press.